Continued FDA approval of iptacopan was contingent on 2-year trial data ...

An international research collaboration led by Queen Mary University of London and University of the Witwatersrand (Wits) in ...

The relationship between cardiovascular dysfunction and renal impairment is widely recognized as the cardiorenal interaction, ...

Chronic kidney disease (CKD) is recognized as a major global health challenge and on the rise nationwide, with approximately ...

Basel, March 29, 2026 – Novartis today announced final two-year results from the Phase III APPLAUSE‑IgAN study of Fabhalta ® (iptacopan) in IgA nephropathy (IgAN). Fabhalta demonstrated a ...

A European cohort of older patients shows that women with advanced CKD report more symptoms than men, but men experience a ...

Chronic kidney disease (CKD) affects nearly 36 million people. “CKD is a real public health crisis, and one that’s steadily rising,” said Merlin Thomas, M.B.Ch.B., Ph.D., FRACP, a professor of ...

Understand genetic kidney diseases, their early warning signs, family risk factors, and when dialysis or transplant may be ...

Equations underestimate the slope of renal decline over time In chronic kidney disease care, the central clinical question is ...

When kidneys fail, toxins and waste build up in the blood. This is why it is important to keep a tab on the health of kidneys ...

MDI Bio Lab scientists discover how the fish solves a basic challenge in regenerative biology-insights in their newest ...

Beets are packed with nutrients—but their oxalate content raises questions for people prone to kidney stones. Here’s what ...